Considering the evidence that chemical chaperones can inhibit chymotrypsin-like activity, here we investigated the potential of PR-957 as a therapeutic drug in a mouse model of Ang II–induced cardiac hypertrophy. The gene discussed is AGT; the disease is cardiac hypertrophy.